AMPEL BioSolutions, LLChttp://www.ampelbiosolutions.com
- Founded: 2013
- CEO: Dr. Peter Lipsky
- Size of Facility: 2500 sq ft
- Company Size: 10
- Funding Source: Grants (e.g. SBIR, CRCF, CIT), Privately Held
- Development Stage: Phase 1-2 Clinical Trials, Pre-clinical
AMPEL BioSolutions is the leading biomedical research think tank that creatively addresses clinical development bottlenecks and R&D roadblocks. AMPEL interrogates, analyzes, synthesizes & interprets the world’s biomedical knowledge to provide novel solutions for clinical research questions. Resourceful and dedicated, AMPEL is composed of leading experts in autoimmunity, immunogenicity, inflammation and clinical immunology with extensive research and medical experience to address and resolve obstacles. AMPEL assists nonprofit organizations, pharmaceutical companies, clinical research groups, and others in basic research, translational medicine, preclinical research, drug development and repositioning, and biomarker identification.